Osmotica Pharmaceutical   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Marietta GA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2007
NCT00558337
First Marketed Drug
2005
nifedipine (procardia)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

OSMOTICA | OSMOTICA PHARM | Osmotica Pharmaceutical Argentina S.A. | Osmotica Pharmaceutical US LLC | Osmotica Pharmaceutical, VP - Global Clinical Development and Medical Affairs | OSMOTICA PHARM CORP | OSMOTICA PHARM US | RevitaLid Inc. | RVL PHARMA INC | RVL PHARMS